Osaka Soda (4046) · InitiativeRestated
Using Retained Earnings for R&D, Capital Expenditure and M&A
First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2023.
4entries
8years
0from disclosures
How it moved
Same theme, other companies
Reinvestment in R&D, capital expenditures and M&AA theme 69 companies write about · 0 as a headwind · 69 as a tailwind
The whole theme swung hardest in 2025: 3 of 36 companies on the "Worse" side.
23 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 69 companies compared. The sentences above are computed from all 69.Full recordFilings, disclosures and news, newest first
- FY2023RestatedAnnual report
「内部留保資金は、企業価値向上のための研究開発や設備投資、M&A等に活用して参ります。」
内部留保を研究開発、設備投資、M&Aに活用する方針を引き続き記載している。 - FY2019RestatedAnnual report
「Retained earnings will be used for R&D, capital investment and M&A to enhance corporate value.」
内部留保の活用先として研究開発、設備投資、Ｍ＆Ａを引き続き掲げている。 - FY2018RestatedAnnual report
「Retained earnings will be used for R&D, capital investment and M&A to enhance corporate value.」
内部留保の活用先として研究開発、設備投資、Ｍ＆Ａを引き続き挙げている。 - FY2016First statedAnnual report
「Retained earnings will be used for R&D, capital investment and M&A to enhance corporate value.」
R&D, capital investment and M&A are identified as specific uses of retained earnings.